GranBio acquires 100 percent equity of American Process Inc
Brazil-headed biotechnology process developer and advanced biofuels and bioproducts producer GranBio Investimentos S.A (GranBio) has announced that it has completed the acquisition of 100 percent equity in US-based American Process Inc. (API) and affiliate companies including AVAPCO LLC and API Intellectual Properties Holdings for an undisclosed amount. GranBio has had a 50 percent stake in API since 2016.
According to a statement, the acquired assets include the Alpena Biorefinery in Alpena, Michigan (MI), the Thomaston Biorefinery and R&D center in Thomaston, Georgia (GA), operations, research, and business development staff and an extensive intellectual property portfolio in the biorefinery, biofuels, biochemicals, and nanocellulose fields with over 200 granted and pending patents.
The acquisition of American Process Inc’s technologies, intellectual property portfolio, and physical assets strengthens GranBio’s market-leading position in the deployment of highly competitive industrial processes for conversion of biomass to renewable fuels, chemicals, and nanocellulose.
Acquiring the GreenPower+, GreenBox+, and AVAP biorefinery technologies and the BioPlus Nanocellulose Technology and their associated world-class demonstration plants and exceptional operations and R&D staff is part of GranBio’s mission to become a global leader in the bioeconomy. As evidenced by the construction and operation of the first commercial-scale cellulosic ethanol plant in Brazil, GranBio is deeply committed to launching innovative biotechnologies that build a better and more environmentally safe planet for the next generations” said Bernardo Gradin, President, GranBio.
GranBio operates the first commercial-scale cellulosic ethanol plant in the Southern Hemisphere. The biorefinery, named Bioflex 1, is located in Alagoas, Brazil, and converts biomass from sugarcane residue, straw and bagasse into “second-generation” cellulosic ethanol.